WASHINGTON — NASA is delaying the launch of the first operational SpaceX commercial crew mission to the first half of November to provide more time to review a problem during a recent Falcon 9 launch attempt.
NASA announced Oct. 10 the Crew-1 mission, which was scheduled to launch on a Falcon 9 in the early morning hours of Oct. 31 from the Kennedy Space Center, will now launch no earlier than early to mid-November.
The delay, the agency said, will provide more time for SpaceX “to complete hardware testing and data reviews as the company evaluates off-nominal behavior of Falcon 9 first stage engine gas generators observed during a recent non-NASA mission launch attempt.” NASA did not identify the specific launch attempt in question, but an Oct. 2 launch of a Falcon 9 carrying a GPS 3 satellite was scrubbed just two seconds before liftoff because of SpaceX Chief Executive
That was the hot take this week from Chris Herd, founder and CEO of remote work setup startup Firstbase. After speaking with about 1,000 companies over the past six months, he estimates that many will be cutting their office space by as much as 40% to 60%. About 90% of workforces indicated that they “never want to be in an office again full-time,” he wrote.
The latest example of the trend is the news this morning that working from home will be a permanent part of the mix at Microsoft. Boosting access to talent, reducing costs, and quality of life were among the benefits of remote work cited by companies in Herd’s informal survey.
“Good thread on the future of work. I agree with him,” former Zillow Group CEO Spencer Rascoff chimed in
Woebot Health announced today it has appointed Monique Levy to the newly-created position of Chief Commercial and Strategy Officer. Reporting to CEO Michael Evers, Levy is responsible for the growth and commercial success of the company’s proprietary therapeutic portfolio and measurement technologies that are designed to improve mental health. The appointment rounds out the company’s executive team, which also includes Founder and President Alison Darcy, Chief Clinical Officer Athena Robinson and Chief Technology Officer Casey Sackett.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005171/en/
Monique Levy, Chief Commercial and Strategy Officer, Woebot Health (Photo: Business Wire)
Evers, who joined Woebot Health in March, said Levy’s formidable experience building businesses and innovating care and health will be instrumental to the company’s next stage of development. “Monique’s training in clinical psychology and experience across some of the world’s most innovative data, digital health and therapeutics businesses bring incredible value
CAESAREA, Israel, Oct. 5, 2020 /PRNewswire/ — IceCure Medical Ltd. (TASE: ICCM), developer of the next generation cryoablation technology that destroys tumors by freezing without the need for surgery, today announced that it has expanded its strategic partnership with Terumo Corporation (Tokyo: 4543) (TRUMY: OTC US), a leading Japanese medical devices company with a global footprint. The expanded partnership reflects the ongoing success of the initial agreement, which was signed in September 2019, and included distribution rights in Japan and Singapore.The new multi-million dollar agreement, which is expected to be finalized by the end of the year, will grant Terumo exclusive rights to distribute IceCure’s products in Thailand for six years, with an option to extend the agreement for an additional six years.
Under the terms of a Letter of Intent (LOI), in exchange for granting exclusive distribution rights and knowledge-sharing for ProSense™ and
Romeo Power has entered into a definitive merger agreement with RMG Acquisition Corp. (NYSE: RMG); upon closing, the combined company will remain listed on the New York Stock Exchange under the new ticker symbol “RMO”
Romeo Power raises $384 million through the business combination, including a $150 million fully committed PIPE anchored by institutional investors as well as strategic investors The Heritage Group and Republic Services
Funding provides for capacity expansion and R&D to further develop the next generation of battery system technologies for commercial vehicles
BorgWarner is a strategic investor and joint venture partner of Romeo Power
The Heritage Group is a strategic investor, PIPE participant and recycling partner of Romeo Power
Republic Services is a strategic investor in the PIPE and intends to enter into a strategic alliance with Romeo Power
Pro forma equity value of the combined company is approximately $1.33 billion
FAIRFIELD, CT — A commercial building in Fairfield recently added two new tenants.
Elinco International Inc. has leased 7,406 square feet of warehouse space on the first floor of 418 Meadow St., while Atmos Air is leasing 3,072 square feet of offices on the second floor, according to a Sept. 25 news release from Southport-based commercial real estate firm Angel Commercial LLC.
“It is great to have found tenants that can utilize the space to help grow their business while remaining in Fairfield,” Angel Commercial LLC President Jon Angel said in the news release. “… The building is in an excellent commuter location with easy access to I-95, Exits 23 & 24.”
Angel was the sole broker in both transactions. Elinco International will take over the space previously occupied by the Fairfield Public Schools maintenance department, according to Jacqueline Greenwood, marketing director for the firm.
It’s been a rough week for Cyberpunk 2077, as Bloomberg’s Jason Schreier reported, and CDPR leadership confirmed, that they were explicitly going back on their previous statements about crunch and mandating that the team work an extra day a week until launch to get the game out on time for its November 19 release.
Schreier reports that really, crunch has been going on for a long time for many members of the CDPR Cyberpunk team, but this was a decree that stated it outright. And CDPR’s Adam Badowski wrote a public statement expressing how hard it was to make the decision and that the “majority” of the team understood:
Now, in an effort to change the topic of conversation, CDPR has debuted a new Cyberpunk trailer starring Keanu Reeves which aired during the NBA game yesterday:
If you didn’t understand Keanu is literally a character in
The first commercially owned U.S. rocket is going to launch into space this Halloween, by way of NASA and Space X.
NASA’s SpaceX Crew-1 flight mission, scheduled to launch on October 31, will carry NASA astronauts Michael Hopkins, Victor Glover, and Shannon Walker, as well as Soichi Noguchi of the Japan Aerospace Exploration Agency, to the space station from NASA’s Kennedy Space Center in Florida, according to a press release.
DUBLIN, Sept. 29, 2020 /PRNewswire/ — The “Passenger Car and Commercial Vehicle Instrument Clusters Market Size Analysis and Outlook to 2026 – Potential Opportunities, Companies and Forecasts for Instrument Clusters application and technology across End User Industries and Countries” report has been added to ResearchAndMarkets.com’s offering.
The Passenger Car and Commercial Vehicle Instrument Clusters market is one of the dynamic digital and display technology segments with major factors such as technological advancements, wide range adoption and large scale applications.
The COVID-19 pandemic has had a negative impact on the market size for the year 2020, with small and medium scale companies struggling to sustain their businesses in the near term future. The Passenger Car and Commercial Vehicle Instrument Clusters market growth has become variable by region with some countries offering huge growth potential while others face closures and low profit margins.
JenaValve Technology, Inc., developer and manufacturer of differentiated pericardial transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, announces the appointment of Peter L. Spadaro, Jr. to the newly created position of Chief Commercial Officer. Mr. Spadaro is a highly accomplished cardiovascular sales and marketing executive who has held senior positions at global industry leaders including Medtronic, St. Jude Medical and most recently Syncardia.
“Peter’s proven success in all aspects of launching and commercializing innovative structural heart devices in the U.S. and internationally clearly makes him the ideal professional to lead this key function at JenaValve as we progress toward commercialization of our technology,” said JenaValve CEO John Kilcoyne. “He brings us unrivaled industry experience including a stellar track record in commercial planning and tactical execution. Peter has the ability to identify and capitalize on market opportunities and brings to JenaValve long established relationships with cardiovascular